HTN articles & resources on Made-in-China.com

Medtronic Is Back at Renal Denervation

Apr 3, 2015

Symplicity Spyral Multi-electrode Renal Denervation Catheter (Image courtesy of Medtronic) The medtech giant isn’t giving up yet on renal denervation, if a new announcement is any indication. Chris Newmarker Medtronic is ...

Tags: Medtronic, Chris Newmarker, Medicine

Recor Medical Announces Major Advances in Its Paradise System for Renal Denervation

Feb 7, 2014

ReCor Medical has announced major advances in its Paradise System for renal denervation (RDN), confirming its commitment to lead in the treatment of patients with resistant hypertension (HTN). The company announced that it has received ...

Tags: renal denervation system, health, HTN

Renal Denervation as a High Blood Pressure Treatment Is Looking Less Exciting by The Day

Jan 23, 2014

Renal denervation as a high blood pressure treatment is looking less exciting by the day, with the latest bad news coming from Covidien. The Dublin, Ireland–based medical device giant said Tuesday that it will exit its OneShot renal ...

Tags: high blood pressure treatment, health

Medtronic's Symplicity System Failed on Efficacy in a Pivotal U.S. Clinical Trial.

Jan 16, 2014

Posted in Cardiovascular by Chris Newmarker on January 15, 2014 Boston Scientific CEO Mike Mahoney remains optimistic about renal denervation and the company’s Vessix platform, even though Medtronic’s Symplicity system failed ...

Tags: Boston Scientific, Mike Mahoney, renal denervation, Vessix platform

Randomization of First Patients in Symplicity HTN-4 Trial is declared by Medtronic

Dec 19, 2013

US-based medical technology company Medtronic has announced the randomization of the first patients in the SYMPLICITY HTN-4 clinical trial at Medical University of South Carolina, Piedmont Heart Institute and Duke University Medical Center. ...

Tags: Health, Medicine

Medtronic Obtained a Device Exemption From FDA to Initiate Symplicity Htn-4 Clinical Trial

Nov 7, 2013

Medtronic has obtained an investigational device exemption from the US Food and Drug Administration (FDA) to initiate SYMPLICITY HTN-4 clinical trial using its Symplicity renal denervation system. SYMPLICITY HTN-4 study has been designed ...

Tags: Medtronic, Medicine

Preliminary Data From Global Symplicity Registry Is Unveiled by Medtronic

Sep 4, 2013

Medtronic has unveiled new data from the Global SYMPLICITY Registry, a multi-centre, prospective, observational registry designed to collect comprehensive data evaluating procedural and long-term safety of the Symplicity renal denervation ...

Tags: Medtronic, Symplicity Registry

Skin Changes in Many Important Ways with Age

May 31, 2013

Skin changes in many important ways with age. The skin becomes thinner, begins to sag, and loses its elasticity and smoothness. On the areas overexposed to UV, like the face and the hands, pigmented age spots appear. To counteract these ...

Tags: Senescence, Skin, Sederma

Medtronic Has Completed Randomizing Symplicity HTN-3

May 24, 2013

Medtronic has completed randomizing Symplicity HTN-3, a clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. Renal denervation is a minimally invasive, catheter-based procedure that decreases the ...

Tags: Medtronic, Randomizing Symplicity

Medtronic Has Submitted IDE to Initiate Symplicity Renal Denervation System Study

Mar 12, 2013

Medtronic has submitted its investigational device exemption (IDE) application to the FDA to initiate a study of its Symplicity renal denervation system for the treatment of uncontrolled hypertension in patients with systolic blood pressure ...

Tags: Medtronic, IDE, FDA

Rox Medical Has Completed The Enrollment of The First Patient in Its Control-Htn Trial

Dec 18, 2012

ROX Medical has completed the enrollment of the first patient in its CONTROL-HTN trial, designed to demonstrate the safety and efficacy of the minimally invasive catheter procedure in treating resistant hypertension. The controlled, ...

Tags: ROX Medical, CONTROL-HTN trial, minimally invasive catheter procedure

Medtronic Has Started Symplicity Renal Denervation System's Clinical Trial in Japan

Dec 18, 2012

Medtronic has begun its minimally invasive Symplicity renal denervation system's clinical trial in Japan to treat patients who are not responding to different types of anti-hypertensive medications and are at risk of stroke. The ...

Tags: Medtronic, clinical trial, medical technology

First Patient Is Enrolled by St Joseph Hospital in Symplicity Htn-3 Trial

Jul 16, 2012

St Joseph Hospital has enrolled first patient for SYMPLICITY HTN-3 trial, conducted by Medtronic, designed to assess investigational Symplicity renal denervation system. Minimally invasive, catheter-based renal denervation procedure is ...

Tags: renal denervation system, catheter-based renal denervation

HTN

Related Products